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It is now 60 years since Zimmerman's classic paper appeared
describing the concept of the mesangium as a structural entity
consisting of both cells and extracellular matrix that occupies
the centrilobular region of the glomerular tuft [1]. The normal
mesangium is now considered to possess two principal cell
populations: the mesangial cell that represents the predominant
type and a resident bone marrow-derived phagocytic cell that
appears capable of a variety of immunological functions. On the
basis of information gleaned from the study of renal biopsies by
immunohistochemistry together with information from several
models of renal disease, it is likely that both these intrinsic cells
play an important role in the initiation and progression of
glomerular injury. These studies, however, have in the main
been of a descriptive nature, documenting the changes in the
number of mesangial cells, the amount of the surrounding
matrix and the infiltration of leukocytes. More recently the use
of tissue culture as a model system to study the mesangial cell
has allowed new insights into the function of this cell, and in
certain cases has permitted speculation as to possible mecha-
nisms that contribute to the pathogenesis of renal disease. Thus
in vitro several studies have provided information about the
response of mesangial cells to co-culture with macrophages and
exposure to soluble mediators including cytokines and growth
factors, vasoactive peptides, lipids, immune complexes and
glucose in an attempt to shed light on glomerular diseases such
as IgA nephropathy, membranoproliferative glomerulonephritis
and diabetic nephropathy in which mesangial cell proliferation
and or expansion of the mesangial matrix are commonly ob-
served.
Mesangial cell in vivo
The general ultrastructural features of the normal mesangial
cell have been described by numerous investigators and will
only be covered here briefly [2—4]. On electron microscopy the
mesangial cell appears quite irregular in shape with numerous
pseudopods of varying length extending into a surrounding
matrix and connected to the glomerular basement membrane.
The cells have an indented nucleus and a relatively small
amount of cytoplasm that contains mitochondria, small vesicles
and lysosomes. The organelles involved in the synthesis and
secretion of proteins, that is, ribosomes, endoplasmic reticulum
and stacked Golgi cisternae are relatively few and poorly
developed. A prominent feature of these cells is the presence of
numerous bundles of small intracellular fibrils and associated
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attachment bodies similar to those found in smooth muscle
cells. The presence of actinomyosin and tropomyosin in this
network has been demonstrated by immunofluorescence with
appropriate antiserum. The similarity of mesangial cells to
smooth muscle cells is further emphasised by the presence of
receptors for angiotensin II on their plasma membrane. In
addition to the above properties, electron microscopic studies
have been interpreted to suggest that the mesangial cell has
phagocytic properties. For example, carbon and ferritin after
intravenous injection soon accumulate within the mesangial
matrix as well as in small vacuoles, multivesicular bodies and
dense bodies of the mesangial cell [5, 6]. In addition to the
intrinsic contractile mesangial cell, Schreiner et al [7] have
documented in the rat a small subpopulation of resident cells
that display many features of macrophages/monocytes. These
cells have Fc and C3b receptors, express the common leuko-
cyte antigen and many also bear Ia determinants. These cells
which account for about 3 to 7% of the mesangial cell popula-
tion are thought to be involved in recognizing and presenting
foreign antigens and to stimulate lymphocyte proliferation
[reviewed in 81.
Function of the mesangial cell
Based on the above morphological findings several functions
have been proposed for the mesangial cell in the normal
glomerulus. Firstly, they act as specialized contractile smooth
muscle cells engaged in the regulation of glomerular hemody-
namics. Secondly, these cells produce extracellular matrix
components which combine in an organized manner to make up
the mesangial matrix and provide structural support to the
glomerular tuft. In addition this matrix modulates mesangial cell
phenotype by affecting cell surface receptor expression.
Thirdly, through their phagocytic properties mesangial cells are
considered to be involved with the uptake and clearance of
macromolecules such as immune complexes from the glomer-
uli. However it is likely that resident mesangial macrophages
also contribute to this process.
In the normal glomerulus these processes are tightly regu-
lated so that the different mechanisms involved with these
functions are coordinated and not inappropriately expressed. In
contrast, numerous renal diseases involving the glomerulus are
characterized by expansion of the mesangial matrix and an
increase in the numbers of cells located within the glomerular
tuft. The increase in cell number is not exclusively the result of
the infiltration of inflammatory leukocytes, but in several dis-
eases is accounted for by mesangial cell proliferation. These
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observations led to the suggestion that mesangial cells partici-
pate in the structural and functional changes that accompany
glomerular disease not only as target cells for cytokines and
growth factors, but also as potential pro-inflammatory cells that
may modify the outcome of glomerular injury. To explore this
possibility and to further our understanding of the function of
the mesangial cell in glomerular hemodynamics, the production
of mesangial matrix and metabolism of foreign proteins several
investigators have carried out experiments with these cells in
vitro.
Tissue culture of intrinsic mesangial cells
The ability to separate and maintain mesangial cells in tissue
culture became possible in the 1970s, and now has been
extensively refined so as to allow researchers to study the
nature of this cell in a more direct and specific manner than is
possible in vivo. Cultures of mesangial cell can be set up by two
principal methods, explanation and enzymatic isolation. Both
use isolated glomeruli as the starting material. In the former
method, mesangial cells are allowed to grow out from whole
glomeruli plated out on plastic culture flasks and maintained in
medium containing a relatively high amount of fetal calf serum.
This method relies on the differential growth capacities of the
intrinsic glomerular cells. In the second approach the whole
glomeruli are pre-incubated with a cocktail of enzymes, usually
proteinases, which collectively modify the glomerular matrices
to generate a glomerular 'core' devoid of endothelial cells and
also the majority of glomerular epithelial cells. This 'core'
consists mostly of mesangium and capillary loops from which
mesangial cells rapidly grow and are established in culture as a
relatively homogenous population. However, as with the ex-
plant method, it is likely that the mesangial cell undergoes many
divisions before sufficient numbers are available for meaningful
studies. Both approaches provide a reliable and reproducible
method for the culture of cells which exhibit several morpho-
logical characteristics of mesangial cells in vivo. In this review
no attempt will be made to discuss the practical details con-
cerned with the tissue culture of mesangial cells such as the
choice of medium and the inclusion of various growth factors
since these have been the subject of several excellent reviews
[9—11]. However, a number of general points concerning the
above methods for the culture of mesangial cells require some
comment since they are relevant to the general aims of this
symposium. The first concerns the biological response of the
mesangial cell to the remodelling of the normal mesangial
extracellular matrix either through the proteolytic action of
intrinsic proteinases or by the addition of enzymes with known
specificity towards the different components of the matrix. The
net result of this remodelling is that mesangial cells are cultured
on plastic and in a two-dimensional system. This is of particular
importance with regards to the mesangial cell since in vivo this
cell, unlike glomerular epithelial and endothelial cells, resides
within a three-dimensional extracellular matrix (ECM). Since in
vivo the quality and quantity of the extracellular matrix pro-
duced by cells in general has been observed to vary with cell
behavior, the composition of the extracellular matrix has been
implicated in the control of cell differentiation and gene expres-
sion, migration and proliferation. Therefore the spatial organi-
zation of the components of the mesangial matrix is likely to
play a critical role in maintaining the normal mesangial cell
phenotype, that is, the quiescent contractile cell defined from
morphological studies. The importance of a three-dimensional
as opposed to a two-dimensional culture system is discussed
later. The second point has in fact already been mentioned in
that the cells have already replicated a large number of times
before the culture can be used for experimental purposes. Thus
the results have to be interpreted in the context of dedifferen-
tiation as well as the the artificial environment of the cultured
cell. A third important point to realize is that a relatively high
concentration of fetal calf serum is required to establish and
maintain mesangial cells in vitro. For the most part such
concentrations are required to provide specific attachment
proteins such as fibronectin and/or laminin and growth factors
such as platelet-derived growth factor necessary for the cells to
proliferate. A consequence of such conditions is that the cells in
culture probably represent activated cells rather than the qui-
escent cell observed in the normal glomerulus.
Another important point to consider is the one of species
difference. Methods for the successful culture of mesangial cells
from several different animal species have been reported.
However, the majority of these studies, particularly the earlier
ones, were undertaken with cells derived from rat glomeruli.
More recently several laboratories have reported on the culture
of human cells. Comparison of the available data has revealed
that a number of important differences exist between human
and rat mesangial cells that must be borne in mind when
extending the results obtained from in vitro studies to human
physiology and pathophysiology [12]. While rat and human cells
appear to be comparable in terms of cell heterogeneity and
production of the mesangial matrix, there are real differences
between these species in relation to the mesangial angiotensin II
receptors (difficult to demonstrate directly in human cells),
intracellular Ca2 metabolism (different sensitivities to PGF2,,
angiotensin I!, serotonin, LTC4/D4 and PAF) [reviewed in 13].
In addition to these examples certain cytokines and proinflam-
matory mediators appear to invoke different responses in rat
compared to human cells. For example, IL-6 is mitogenic for rat
mesangial cells [14] but not for human cells [15]. Again rat cells
secrete TNF-a when stimulated with LPS [161, a finding that
was not repeated in human cells using a radioimmune assay and
Northern blot [17] or polymerase chain reaction [18] as the
detection methods. There are also marked differences in the
ranking order of potency and metabolism among eicosanoids
between the species. Rat cells in culture release mainly PGE2
[19] while their human counterparts produce mainly PG!2 [20].
Phagocytosis linked to generation of reactive oxygen species is
not so clearly demonstrated in human cells compared to rat
cells [21]. Finally recent evidence suggests that human and rat
cells respond differently in the up-regulation of the 72K and the
94K type IV collagenases in response to IL-i and TNF-a [22].
Identification of mesangial cells in vitro
The purity and characterization of the mesangial cell in vitro
has always been a problem since, unlike the endothelial cell
which can readily be identified by the demonstration of factor
VIII, the mesangial cell does not express a specific protein
which readily distinguishes it from the other cells of the
glomerulus [13, 23]. The possible exception is the rat mesangial
cell which in vivo expresses the Thy 1.1 antigen on its cell
surface. Usually cells isolated from glomeruli and grown in
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Table 1. Expression of some receptors on mesangial cells and some
consequence of their activation
Potential responsesReceptor
Angiotensin II
Cytokines
Adenosine
Growth factors
Endothelin
Prostaglandin
Prostaglandins
IL-i
Contraction
Bioactive lipids
IL-6 ROS
IL-8 Matrix
TNF-a Proteinases
PDFG TIMP
TGF-/3
Fc ROS
Integrins
two-dimensional culture are characterized as intrinsic mesan-
gial cells by immunofluoresence staining to reveal prominent
intracellular cytoskeletal fibrils of actin and smooth muscle
specific myosin (indicative of contractile cells), desmin and
vimentin arranged along the axis of the cell and the absence of
factor VIII, cytokeratins and angiotensin-converting enzyme
activity, common leukocyte antigen, and in the case of rat cells
Ia antigen. In confluent culture the cells lack the morphological
features such as the close cell-cell contact typical of endothelial
and epithelial cells and resemble smooth muscle cells. They
grow in multilayers and exhibit two morphological phenotypes:
fusiform, or elongated and stellate. Electron microscopy con-
firms the above features, with the additional findings in some
cells of a prominent and wide-spread endoplasmic reticulum
and large Golgi complex and copious extracellular matrix. The
above features are reminiscent of arterial smooth muscle cells
in culture which also exist as two phenotypes, namely contrac-
tile and synthetic. As yet little information is available on the
relative metabolic activities of the two mesangial cell pheno-
types. However, it has been reported that in long-term culture
these cells form hillocks composed of cells embedded in extra-
cellular matrix [24]. Under these conditions the two mesangial
cell phenotypes exhibit different responses to fetal calf serum
[25].
Mesangial cell receptors and growth factors
Despite the many limitations of working with mesangial cells
in vitro, the ability to study these cells in culture has greatly
facilitated the study of mesangial cell biochemistry, growth, and
metabolism at the cellular level. As shown in Table 1 numerous
receptors for biomolecules have been identified on the mesan-
gial cell membrane. This list includes receptors for eicosanoids
and neuropeptides, as well as the more recognized growth
factors such IL-i, PDGF and IGF-1. Interaction of the appro-
priate ligand with its receptors results in a number of responses
which have been investigated in terms of mesangial contractil-
ity, cell proliferation and production of matrix.
Table 2. The interaction of vasoactive substances with mesangial
cells
Short term
Long term
Cell Matrix
Agonist contraction growth Coll/FN POE2
Angiotensin II + + + — +
AVP + + — +
Serotonin + + — +
Adenosine + +
ET-l + +
TXA2 + + + + +
ANP - -
EDRF (NO) -
POE2 — — — —
For references see text.
Vasoactive peptides and eicosanoids
Table 2 indicates that co-culture of mesangial cells with
vasoactive peptides can induce contraction or relaxation of the
cells depending on the ligand. The contraction of mesangial
cells when cultured with angiotensin II, vasopressin and nor-
epinenhnne was first demonstrated in 1980 [26, 27]. These
observations have been confirmed by several workers, and the
number of ligands that cause contraction have been extended to
include endothelin-l, thromboxane, adenosine, and serotonin
[13]. These in vitro observations correlate well with the effects
of the agonists in vivo. The contraction in response to an agonist
is associated with specific binding, is blocked by receptor
antagonists such as sar'-ala8 angiotensin II for angiotensin II
and phenoxybenzamine for norepinephrine, and reversible
upon removal of agonist. The process is dependant on Ca2 and
is accompanied by the production of PGE2. Binding of the
agonist to the receptor activates phospholipase C to cleave
phosphatidylinositol biphosphate with the formation of two
second messengers, inositol triphosphate (1P3) and diacyiglyc-
erol (DAG). As in other systems the 1P3 so generated releases
Ca2 from intracellular storage sites, which result in a rapid
increase in intracellular calcium. The Ca2 binds to calmodulin
which in turn activates a number of Ca-dependent enzymes,
including the activation of myosin light chain kinase with
subsequent phosphorylation of a myosin light chain leading to
contraction. The 1P3/calcium signal is transient, and is attenu-
ated by activation of protein kinase C. This mechanism there-
fore represents a short-term effect on mesangial cells. DAG
activates protein kinase C leading to phosphorylation of specific
proteins which in turn bring about the stimulation of eicosanoid
production and cell contraction. Since vasodilator rather than
vasoconstrictor prostaglandins predominate, it is likely that
PGE2 (in the case of the rat) and PGI2 (with human cells)
function in a negative feedback manner to attenuate the action
of the vasoconstrictor peptides.
The vasoactive peptides, in addition to their effect on mesan-
gial cell tone, exert many other multiple biological effects,
including the induction of the oncogenes c-los and c-fun,
alterations of the synthesis of extracellular and intracellular
proteins and cell growth [28, 29].
Table 2 also indicates that the same vasoconstrictors have a
long-term effect on mesangial cells which respond in terms of
cell proliferation and the production of PDGF. The ability of
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Table 3. Mechanisms of interaction of growth factors with mesangial
cells
Growth factor
Receptor
tyrosine kinase
Induces
PDGF AA
PGDF
bFGF
EGF
IGF-l
+
+
+
+
+
+
?
+
Serotinin
Endothelin
Angiotensin II
—
—
—
?
+
+
IL-i
IL-6
IL-8
TGF-/3
—
—
—
—
+
+
?
+
For references see text.
PDGF to act as an autocoid may explain the mitogenic effects of
these vasoactive peptides, but as yet there is no conclusive
evidence to support this claim. Another possibility is that these
vasoactive agents share with the growth factor EGF common
intermediates in the signalling pathway and also common ty-
rosine kinases which phosphorylate these intermediates [301.
Growth factors
Table 3 lists a number of agents claimed to be mitogenic for
mesangial cells or involved in some way in mesangial cell
proliferation. The interaction of these molecules with cells in
culture including mesangial cells has been examined in detail by
several workers and has been extensively reviewed [3 1—33]. In
this review a number general points will be made. The first
concerns the interpretation of the data to the situation in vivo.
The ability of any growth factor or cytokine to stimulate
replication in culture may depend on alterations in the cells'
metabolic balance that are irrelevant to initiation of replication
in vivo. From extensive studies with vascular smooth muscle
cells (VSMC) it has been suggested that the changes undergone
by these cells in culture which includes the loss of contractile
proteins and the appearance of a large amounts of endoplasmic
reticulum is in some way linked to the new found ability of the
cells to respond to mitogens [34]. Furthermore, it is interesting
to note that infusion of rPDGF BB (which acts on all PDGF
receptors) has been shown to stimulate intimal and medial
VSMC proliferation in rat carotid arteries, but only after they
were previously subjected to injury, whereas no effect was
obtained in uninjured arteries [35]. This indicates that VSMC
can respond to PDGF in vivo but the responsiveness is closely
regulated. Glomerular mesangial cells in the normal adult
kidney show essentially no replication but, like VSMC, in
culture undergo a change in phenotype and readily proliferate in
response to growth factors such as PDGF, bFGF and IGF-1.
This poses the question: which of the above mitogens initiate
proliferation of the normally quiescent mesangial cells in vivo?
Thus in vitro studies on mesangial cell proliferation by mitogens
require parallel experiments to determine whether mesangial
cells express receptors for molecules such as PDGF and bFGF
in vivo and to determine what the in vivo effect on the kidney of
perfusion of these mitogens. A number of recent publications
have reported on such experiments in relation to PDGF and
bFGF (reviewed by J Floege in this issue).
The second point is to note that all of the polypeptide growth
factors mitogenic for mesangial cells also stimulate fibroblasts
and VSMC to proliferate. This indicates that there is a common
mode of action for all these cell types in response to these
mitogens. In general these agents can be subdivided into: (i)
those that appear to have a direct mitogenic effect (PDGF,
bFGF, EGF and IGF-1), (ii) those that are likely to be indirect
(IL-i and TGF-/3) and induce the formation of a direct mitogen
such as PDGF; and (iii) an intermediate group that may have
both direct and indirect mitogenic actions (endothelin and
angiotensin II). The growth factors can also be subdivided
according to the known properties of their receptors. The direct
mitogens have in common an intrinsic tyrosine kinase activity,
whereas those with indirect action do not.
The third point to emphasize from the experiments with
growth factors is that once activated the mesangial cell may
themselves produce cytokines, growth factors and other prom-
flammatory factors. Among these are IL-i and PDGF, and since
mesangial cells express receptors for both these molecules it
indicates that the cells have the potential to be involved in
autocrine activity or act in a paracrine manner to stimulate the
other cells of the glomerulus (Fig. 1).
Eicosanoids
The stimulation of mesangial cells with appropriate ligands
has demonstrated production of the vasodilator PGE2 and to a
lesser extent PGI2, as well as the vasoconstrictor eicosanoid
prostaglandin F2a and thromboxane. In addition to their well
documented effect on mesangial cell tone, it is now apparent
that prostaglandins and thromboxane may be important medi-
ators in the regulation of extracellular matrix formation. Thus
thromboxane may function to up-regulate matrix synthesis,
whereas prostaglandins may act in a co-ordinate and opposite
manner to reduce matrix formation.
Mesangial matrix
As visualized by immunofluorescence the major constituents
of the mesangial matrix are the collagens types IV and V, the
glycoproteins laminin and fibronectin, and the proteoglycans
heparan sulphate (perlecan) and chondroitin/dermatan sul-
phates (versican, decorin and biglycan) all of which are synthe-
sized by mesangial cells in culture (J Couchman, this volume).
In addition mesangial cells in vitro synthesize relatively large
amounts of the interstitial collagens, proteins not normally
associated with the glomerulus. Mesangial cells also synthesize
all the different classes of proteinases of which the metallopro-
teinases (MMP) and their specific inhibitors (TIMPs) have
received particular attention [36]. Since in vitro MMP and
TIMP as well as the individual components that make up the
mesangial matrix are subject to regulation by different cyto-
kines and growth factors, tissue culture provides a useful model
system with which to investigate the turnover of the mesangial
extracellular matrix in relation to a number of glomerular
diseases.
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Fig. 1. Cell-cell interactions involving the mesangial cell with intrinsic glomerular epithelial and endothelial cells and infiltrating macrophages.
Possible cell-cell interaction between the glomerular mesangial cell with: (A) endothelial cell; (B) epithelial cell; (C) mesangial cell; and (D)
infiltrating leukocytes. The responses of the mesangial cell to various molecules is indicated in terms of up-regulation (+) and down-regulation (—).
The mesangial cell once activated will produce cytokines that have autocrine activity (C) or act in a paracrine manner to activate endothelial (A)
or epithelial (B) cells, Most, but not all, of the interactions initiate up-regulation and initiate mesangial cell proliferation, enhance matrix
metabolism or the secretion of proinflammatory molecules. Some, however, such as heparan sulphate, TGF-)3 and in one report IL-i, have a
down-regulatory action.
Tissue culture as models for specific glomerular diseases
Diabetes
To clarify the role of glucose in diabetic glomerulopathy
mesangial cells have been cultured in media containing physi-
ological (5 mM) and elevated (30 mM) glucose concentrations
[37—40]. In general this approach has indicated that high levels
of this sugar induce an alteration in the turnover of most of the
molecules associated with the mesangial matrix. Thus both cell
associated- and secreted type IV collagen, laminin and fi-
bronectin increase. These results were independent of the
proliferative state of the cell and were not reproduced in
osmotic control media containing either mannitol or L-glucose.
Furthermore, kinetic data on the degradation of the matrix
I PROSTAGLANDIN
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molecules by mesangial cells suggested that the catabolism of
these proteins was unchanged under hyperglycemic culture
conditions. Taken together these in vitro results indicate that
the mechanism involved in the accumulation of extracellular
material in diabetic nephropathy involve increased biosynthesis
rather than a perturbation in the matrix-degrading activity of
mesangial cells. However, a defect in the mesangial degradative
pathway cannot be totally ruled out as recent work by Kitamura
[41], while confirming that high glucose up-regulates message
for the extracellular matrix molecules, found that the gene
expression for TIMP and metalloproteinases also regulate in a
manner indicating that a decrease in matrix-degrading activity
as well as increases in matrix production occurs in diabetic
mesangial cells. In contrast to the above results with type IV
collagen, fibronectin and laminin, hyperglycemic culture media
decrease proteoglycan synthesis by human and porcine mesan-
gial cells [42, 43]. These observations, which require confirma-
tion at the transcription level, would appear to complement
earlier observations that proteoglycan synthesis is reduced
when the basement-producing tumor (EHS-sarcoma) is grown
in hyperglycemic diabetic mice or in genetically diabetic mice
[44].
Lipid
The detection of lipoprotein deposits in endothelial and
mesangial cells and in the mesangium of diseased glomeruli has
stimulated in vitro studies on mesangial cell-lipoprotein inter-
actions. Results to date indicate that while both rat and human
cell express the classical receptor for LDL, only the rat
possesses the scavenger receptor [45—49]. Exposure of human
cells to physiological doses of native LDL initiates a small
increase in proliferation which is accompanied by a modest up
regulation in eicosanoid production [50]. Although this may be
viewed as evidence for activation of mesangial cells the effect of
the lipoprotein may represent an increase in the supply of
cholesterol, a nutrient essential for cell membrane synthesis.
Since recent studies have demonstrated that LDL enhances the
proliferative response of mesangial cells to endothelin-1 and
PDGF, LDL may not be mitogenic for mesangial cells and more
likely acts as a competence factor for the proliferation induced
by exposure of cells to growth factors and cytokines [49, 51J.
Rat, human and guinea pig mesangial cells all oxidize LDL
probably through the auto-generation of reactive oxygen spe-
cies [52—54]. In contrast to native LDL, this form of the
lipoprotein at doses between 25 to 50 g protein/ml suppresses
cell proliferation but at higher levels (> 100 g/ml) causes
serious toxicity to mesangial cells. Oxidized LDL, even at
doses < 40 pg/m1, dramatically increases in a concentration
dependent manner PGE2, PGI2 and TXB2 synthesis production
by human cells in culture [47, 50, 531. With other cell types in
vitro, including vascular smooth muscle cells, LDL has been
shown to modify the secretion of cytokines and growth factors
as well as matrix components. For rat mesangial cells native
LDL up-regulates type IV collagen gene expression and protein
synthesis while the human cell message for fibronectin is
likewise affected [55, 561. As yet no similar data are available
from studies with oxidized LDL.
Complement and immune complexes
The effect of immune complexes and the terminal attack
complex on mesangial cells in vitro has clearly indicated that
these cells are not mere target cells but behave like true
inflammatory cells. Thus when stimulated with C5b-9 at con-
centrations which do not induce cell lysis, they respond with
the increased production of several proinflammatory molecules
including interleukin-l, interleukin-6, tumor necrosis factor,
different eicosanoids, reactive oxygen products and enhanced
production of extracellular matrix [57—60].
Despite the fact that IgA immune complexes (IC) are consid-
ered the primary cause of IgA nephropathy relatively little is
known about the interaction between these IC with mesangial
cells in vitro. The limited data available suggest that IgA
circulating IC are not directly involved in mesangial cell prolif-
eration [611. However, it is well documented that soluble
IgG-IC stimulate the production of IL-I, IL-6 and superoxide
production, and mobilize free Ca2 from intracellular stores in
a dose- and time-dependent manner via the Fc receptor [62—651.
Conclusions
Thus far this article has concentrated on data obtained in the
main from the culture of mesangial cells on plastic or culture
vessels preincubated with either collagen, fibronectin and in
some cases serum. However, it must be borne in mind that in
vivo the cells exist in a three-dimensional matrix, and further-
more they do not exist in isolation but cohabit with the other
intrinsic glomerular cells and in certain circumstances with
infiltrating leukocytes.
The problems associated with growing the cells embedded in
a three-dimensional matrix have recently been addressed by
Madri and coworkers [66, 67] who cultured mesangial cells in
native type I collagen. While the use of this collagen is not
entirely in keeping with the composition of the normal mesan-
gial matrix, it did serve to demonstrate that in three-dimen-
sional culture mesangial cells show a low proliferative level.
They also fail to respond to PDGF AA and BB due to down-
regulation of the PDGF receptor. Clearly this is an important
observation in relation to the interpretation of the data obtained
from in vitro experiments, and questions the value of informa-
tion obtained with other growth factors. It will be of interest to
determine the influence of the three-dimensional culture system
on the ability of mesangial cells to synthesize collagen, proteo-
glycans and glycoproteins. For example, will interstitial colla-
gen and small dermatan sulphate proteoglycans still constitute
the major matrix molecules synthesized, or will type IV colla-
gen and heparan sulphate proteoglycans, which represent the
principal matrix components in vivo, become the predominant
species?
In addition to influence of matrix on mesangial cell behavior
it is likely that a complex interaction exists between the
different cell types of the glomerulus. This aspect of tissue
culture has largely been ignored but some information is avail-
able. Studies on rat mesangial cells co-cultured with macro-
phages show an enhanced synthesis of type IV collagenase
activity by as much as 30-fold, probably by a mechanism
involving IL-i [68]. Possible cross-talk between glomerular
epithelial cells and mesangial cells is suggested by the finding
that a heparin-like molecule extracted from culture medium
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conditioned by glomerular epithelial cells inhibits mesangial cell
growth [69]. Finally, in a model of endothelial cell and mesan-
gial cell co-culture, it has been demonstrated that a chronic
interaction between these cells occurs through the release of
ET- 1 from the endothelial cell and the resulting enhanced
synthesis of PGE2 by the mesangial cell [70]. The above
interactions, together with other examples of potential cross-
talk between mesangial cells and the other cells of the glomer-
ulus, are included in Figure 1.
Reprint requests to Malcolm Davies, Ph.D., Institute of Nephrology,
University of Wales College of Medicine, Royal Infirmary, CardiJJ CF2
JSZ Wales, United Kingdom.
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